跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Triplixam - SFDA Drug Approval Details
Approvals
/
SFDA
/
Triplixam
Authorized
NCE
Triplixam
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
ca92e68efbba05bd
Company
Unknown
Type
NCE
Approval Details
Approval Id
ca92e68efbba05bd
Drug Approval Sfda Name
Triplixam
Trade Name
Triplixam
Generic Name
PERINDOPRIL ARGININE,INDAPAMIDE,AMLODIPINE BESILATE
Register Number
0510234309
Register Year
2023
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Bottle
Package Size
30
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
21000001718-17.5-100000073665
Price
133.3
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
ca92e68efbba05bd
Type
NCE
Back to SFDA Approvals